ACPU Welcomes Inaugural Corporate Members

The Association of Clinical Pharmacology Units formally welcomed eight inaugural clinical research organizations into ACPU’s new corporate membership program.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
Eight clinical research units have enrolled in ACPU's new corporate membership program.

Delaware (PRWEB) August 20, 2014

The Association of Clinical Pharmacology Units (ACPU), formally welcomed eight inaugural clinical research organizations into ACPU’s new corporate membership program, including AbbVie, Compass Research, Covance, New Orleans Center for Clinical Research & Volunteer Research Group (NOCCR & VRG), Orlando Clinical Research, PRA Health Sciences, Quintiles, and Worldwide Clinical Trials.

Angela Baker, ACPU President said, “ACPU appreciates the enthusiastic response to our inaugural offering of corporate membership and is especially pleased with the diversification of these initial corporate members which represent large clinical research organizations, a pharmaceutical owned CRU, and smaller niche CRUs across the country. With the first members of our new corporate membership program we begin a new era for ACPU, allowing us to work more closely with CPUs and their staff to meet the growing complexity of operational challenges in early phase study conduct.”

Baker also pointed out that each corporate member nominates up to ten employees as individual voting members and remarked that this will significantly expand the role of individual voting members.

At ACPU’s 2013 Annual Meeting last October, Donna Dorozinsky, ACPU’s Immediate Past President, announced the creation of a new corporate membership class as well as a strategic partnership with HealthCarePoint to provide new ACPU corporate members with access to HealthCarePoint’s buying club and PET-ABC® (Professional Quality management software) in addition to discounted access to their TrainingCampus eLearning system.

Dr. William Smith, President of New Orleans Center for Clinical Research and Volunteer Research Group (NOCCR & VRG) and President-elect of ACPU, said, “I’m pleased that NOCCR & VRG can directly support ACPU’s efforts to promote standards of practice and guidelines for early phase clinical research activities through corporate membership.” Dr. Smith also pointed out that NOCCR & VRG’s employees are excited to participate in ACPU programs and remarked that he is looking forward to his research unit’s access to the products offered by HealthCarePoint in partnership with ACPU.

About ACPU
ACPU is the home for the Clinical Pharmacology Unit community. While other groups address the science of early phase studies, ACPU is the only organization that provides support for CPUs and staff to meet the significant operational challenges of early phase study conduct. ACPU members are a community of Clinical Pharmacology Units, their staff, and CPU support professions. For more information please visit http://www.acpu.net.


Contact